Aragen Life Sciences is exhibiting at the EFMC conference in Booth #62 on September 6-10 to discuss targeted protein degrader programs and integrated drug discovery strategies.

Public source

Publisher name

Public post

Advancing a Targeted Protein Degrader (TPD) program or navigating complex medicinal chemistry challenges? Visit Aragen at EFMC Booth #62 (Sep 6-10) to discuss complex ch…

Log in to read the full post

Company

Aragen Life Sciences

Industry
Pharmaceutical Manufacturing
Location
Hyderabad, IN
Company size
1,001–5,000 employees

About Aragen Life Sciences

Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health. Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement. At Aragen, we recognize your work is vital, urgent and impacts lives. Our purpose, ‘In every molecule is the possibility for better health’ motivates us to drive the success of your programs, so that we can together transform hope into health for millions of people around the world.

See more

Latest activity

9 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.